BEAM - Beam Therapeutics Inc.
IEX Last Trade
28.56
-0.340 -1.190%
Share volume: 9,054
Last Updated: Thu 26 Dec 2024 08:30:21 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$28.90
-0.34
-1.18%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-07 | 2023-02-28 | 2023-05-10 | 2023-08-08 | 2023-11-08 | 2024-02-27 | 2024-05-07 | |
| Total revenue | 16.652 M | 15.799 M | 20.037 M | 24.208 M | 20.116 M | 17.193 M | 316.192 M | 7.410 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 16.652 M | 15.799 M | 20.037 M | 24.208 M | 20.116 M | 17.193 M | 316.192 M | 7.410 M | |
| -5.12% | 26.82% | 20.82% | -16.90% | -14.53% | 1,739.07% | -97.66% | |||
| Operating expenses | 98.618 M | 107.102 M | 109.022 M | 123.136 M | 122.264 M | 125.460 M | 183.334 M | 111.542 M | |
| Selling general and admin | 24.062 M | 21.815 M | 22.681 M | 23.490 M | 24.656 M | 25.410 M | 43.257 M | 26.724 M | |
| Research and development | 74.556 M | 85.287 M | 86.341 M | 99.646 M | 97.608 M | 100.050 M | 140.077 M | 84.818 M | |
| Total expenses | 98.618 M | 107.102 M | 109.022 M | 123.136 M | 122.264 M | 125.460 M | 183.334 M | 111.542 M | |
| 8.60% | 1.79% | 12.95% | -0.71% | 2.61% | 46.13% | -39.16% | |||
| Operating income | -81.966 M | -91.303 M | -88.985 M | -98.928 M | -102.148 M | -108.267 M | 132.858 M | -104.132 M | |
| Ebit | -81.966 M | -116.803 M | -88.985 M | -98.928 M | -102.148 M | -108.267 M | 132.858 M | -104.132 M | |
| Pretax income | -71.950 M | -107.165 M | -37.349 M | -96.460 M | -82.776 M | -96.088 M | 144.163 M | -98.669 M | |
| 48.94% | -65.15% | 158.27% | -14.19% | 16.08% | -250.03% | -168.44% | |||
| Income tax | 0.000 | 2.410 M | 1.000 M | 0.000 | 0.000 | 0.000 | 1.366 M | 0.000 | |
| Net income basic | -71.950 M | -109.575 M | -38.349 M | -96.460 M | -82.776 M | -96.088 M | 142.797 M | -98.669 M | |
| -52.29% | 65.00% | -151.53% | 14.19% | -16.08% | 248.61% | -169.10% | |||
| Net income | -71.950 M | -109.575 M | -38.349 M | -96.460 M | -82.776 M | -96.088 M | 142.797 M | -98.669 M | |
| -52.29% | 65.00% | -151.53% | 14.19% | -16.08% | 248.61% | -169.10% |